Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study
- PMID: 15846250
- DOI: 10.1016/j.ahj.2004.06.022
Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study
Abstract
Background: Early lumen loss (ELL) may be detected in patients undergoing coronary interventions for in-stent restenosis. This phenomenon may contribute to recurrences. This prospective, randomized study was designed to determine if repeat stent implantation may prevent ELL in patients with in-stent restenosis.
Methods: Forty patients were randomized: 20 were allocated to elective stent implantation and 20 to conventional balloon angioplasty. Quantitative coronary angiography and intravascular ultrasound (IVUS) volumetric studies were systematically performed (1) before the procedure, (2) immediately after intervention, and (3) 30 to 60 minutes later.
Results: Baseline characteristics were similar in both groups. After the delay time interval (46 +/- 8 minutes), quantitative coronary angiography revealed a significant reduction in minimal lumen diameter (2.2 +/- 0.5 mm vs 1.7 +/- 0.5 mm, P < .001) in the balloon angioplasty arm. Likewise, in this group, IVUS demonstrated a reduction in mean lumen area (7.1 +/- 2 mm2 vs 6.2 +/- 2 mm2 , P < .001) and lumen volume (144 +/- 59 mm3 vs 126 +/- 54 mm3 , P < .001). In 4 of these patients, ELL was severe enough to require further intervention. In the stent arm, however, angiographic data and IVUS mean lumen area (7.7 +/- 3 mm2 vs 7.7 +/- 3 mm2) and lumen volume (161 +/- 72 mm3 vs 160 +/- 69 mm3) remained unchanged after the delay time interval. On multivariate analysis, stent implantation was an independent predictor of the absence of ELL by quantitative coronary angiography and by IVUS. In addition, patients with a larger ELL on IVUS had a lower event-free survival at 1 year (40% vs 79%, log rank P = .003).
Conclusions: This randomized study demonstrates that (1) ELL is frequently detected after treatment of in-stent restenosis with balloon angioplasty, that (2) ELL influences the long-term clinical outcome of these patients, and that (3) repeat stent implantation prevents ELL.
Similar articles
-
Randomized trial of conventional balloon angioplasty versus cutting balloon for in-stent restenosis. Acute and 24-hour angiographic and intravascular ultrasound changes and long-term follow-up.Ital Heart J. 2004 Apr;5(4):271-9. Ital Heart J. 2004. PMID: 15185885 Clinical Trial.
-
A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.J Am Coll Cardiol. 2006 Jun 6;47(11):2152-60. doi: 10.1016/j.jacc.2005.10.078. J Am Coll Cardiol. 2006. PMID: 16750678 Clinical Trial.
-
Preventive effect of an antiallergic drug, pemirolast potassium, on restenosis after stent placement: quantitative coronary angiography and intravascular ultrasound studies.J Cardiol. 2003 Jul;42(1):13-22. J Cardiol. 2003. PMID: 12892037
-
[New methods of coronary imaging II. Intracoronary ultrasonography in clinical practice].Ital Heart J Suppl. 2001 Jun;2(6):579-92. Ital Heart J Suppl. 2001. PMID: 11460831 Review. Italian.
-
Serial intravascular ultrasound assessment of the efficacy of intracoronary gamma radiation for preventing recurrent in-stent restenosis.Minerva Cardioangiol. 2002 Oct;50(5):507-15. Minerva Cardioangiol. 2002. PMID: 12384633 Review.
Cited by
-
Current Management of In-Stent Restenosis.Korean Circ J. 2018 May;48(5):337-349. doi: 10.4070/kcj.2018.0103. Korean Circ J. 2018. PMID: 29737639 Free PMC article. Review.
-
In-Stent Restenosis: Incidence, Mechanisms, and Treatment Options.Curr Cardiol Rep. 2025 Jun 19;27(1):96. doi: 10.1007/s11886-025-02249-0. Curr Cardiol Rep. 2025. PMID: 40536538 Review.
-
Management of in-stent restenosis.EuroIntervention. 2022 Jun 3;18(2):e103-e123. doi: 10.4244/EIJ-D-21-01034. EuroIntervention. 2022. PMID: 35656726 Free PMC article.
-
Is Coronary Brachytherapy Staging a Comeback for the Treatment of In-Stent Restenosis?Curr Cardiol Rep. 2021 Oct 1;23(11):156. doi: 10.1007/s11886-021-01582-4. Curr Cardiol Rep. 2021. PMID: 34599432 Review.
-
Comparative efficacy of interventional therapies and devices for coronary in-stent restenosis: A systematic review and network meta-analysis of randomized controlled trials.Heliyon. 2024 Mar 8;10(6):e27521. doi: 10.1016/j.heliyon.2024.e27521. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38496861 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical